Data-Driven Decision Making

A new deal between Fushi Tech and tea giant PlayMade shows how AI and CRM are becoming critical tools for survival and growth in a competitive market.

Match Group bets big on the future of dating, spinning out an AI venture while a new CEO steers Hinge toward its projected $1 billion revenue goal.

A $3 billion drop in assets at AllianceBernstein, driven by client withdrawals in a flat market, signals a deeper challenge for active asset managers.

A new campaign tackles undiagnosed kidney disease. But is it just public health, or a savvy strategy to reshape a multi-billion dollar market?

Advanced AI is reshaping how destinations target travelers. These data-driven strategies offer a powerful playbook for healthcare's patient engagement challenges.

Beyond webinars, ON24's G2 win and LinkedIn pact reveal a strategic shift to AI-driven data and connected campaigns in the B2B marketing tech war.

A Chinese biotech is pioneering next-gen cancer drugs that promise higher precision and fewer side effects. Is this the future of oncology treatment?

The creator economy has mastered ROI-driven engagement. Can healthcare use its AI-powered playbook to improve patient outcomes and combat misinformation?

As AI-native fintech Henon plants its flag in London, its push for 'zero-error' finance signals a new competitive era for private capital in EMEA.

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

A $2.4B tech acquisition seems distant from healthcare, but Qualcomm's move to buy Alphawave is building the essential AI infrastructure for medicine's future.

Allbirds co-founder Joey Zwillinger is applying consumer tech disruption to women's health. Can Biologica's science-backed model reshape a stagnant market?

A new $500M USACE contract shows how Tetra Tech is turning advanced AI and data analytics into profitable solutions for America's toxic waste problems.

Facing federal overhaul and public outcry, top organizations pledge reform. Can innovation and transparency fix a broken system and save thousands of lives?

Angeion Group's appointment of a legal marketing veteran isn't just a new hire; it's a calculated move to challenge rivals and dominate its niche.

LRN appoints Bob Lemmond as CEO, a strategic move signaling a deeper push into data-driven ethics amid rising AI regulations and market complexity.

A new partnership aims to turn dusty tape libraries into revenue streams using AI, marking a major strategic shift for a legacy hardware maker.

A.D.A.M. Innovations just launched ALUNAÉ, the world's first AI genomic-based skincare. Is this the future of beauty or a step too far?

Groundbreaking lymphoma data and a strategic acquisition position Natera to dominate the liquid biopsy market, challenging old standards and creating new value.